Analysis

DOJ Has Few Allies, Many Foes In High Court Opioid Brawl

By Jeff Overley (February 25, 2022, 10:46 PM EST) -- It seemed like a marquee win for the U.S. Department of Justice: The felony conviction of an Alabama doctor who prescribed fentanyl in quantities so immense he may have influenced a drugmaker's stock price. But as U.S. Supreme Court justices are set to scrutinize the conviction on Tuesday, numerous scholars and corporate groups are calling it ominous and unfair, with virtually no one backing the DOJ.

The outcry stems from an Eleventh Circuit opinion that mostly upheld a guilty verdict against Yellowhammer State pain specialist Dr. Xiulu Ruan. According to prosecutors, Ruan became the nation's top prescriber of a Galena Biopharma...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!